BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33064887)

  • 1. Polymorphisms of the μ-opioid receptor gene influence cerebral pain processing in fibromyalgia.
    Ellerbrock I; Sandström A; Tour J; Kadetoff D; Schalling M; Jensen KB; Kosek E
    Eur J Pain; 2021 Feb; 25(2):398-414. PubMed ID: 33064887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The OPRM1 gene and interactions with the 5-HT1a gene regulate conditioned pain modulation in fibromyalgia patients and healthy controls.
    Tour J; Sandström A; Kadetoff D; Schalling M; Kosek E
    PLoS One; 2022; 17(11):e0277427. PubMed ID: 36342939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-to-gene interactions regulate endogenous pain modulation in fibromyalgia patients and healthy controls-antagonistic effects between opioid and serotonin-related genes.
    Tour J; Löfgren M; Mannerkorpi K; Gerdle B; Larsson A; Palstam A; Bileviciute-Ljungar I; Bjersing J; Martin I; Ernberg M; Schalling M; Kosek E
    Pain; 2017 Jul; 158(7):1194-1203. PubMed ID: 28282362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia.
    Solak Ö; Erdoğan MÖ; Yıldız H; Ulaşlı AM; Yaman F; Terzi ES; Ulu S; Dündar Ü; Solak M
    Rheumatol Int; 2014 Sep; 34(9):1257-61. PubMed ID: 24671502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of functional polymorphisms of opioid receptor mu 1 and catechol-O-methyltransferase on the neural processing of pain.
    Cheong Y; Lee S; Okazawa H; Kosaka H; Jung M
    Psychiatry Clin Neurosci; 2024 May; 78(5):300-308. PubMed ID: 38403942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The translocator protein gene is associated with symptom severity and cerebral pain processing in fibromyalgia.
    Kosek E; Martinsen S; Gerdle B; Mannerkorpi K; Löfgren M; Bileviciute-Ljungar I; Fransson P; Schalling M; Ingvar M; Ernberg M; Jensen KB
    Brain Behav Immun; 2016 Nov; 58():218-227. PubMed ID: 27448744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic gene-to-gene interaction is associated with mood and GABA concentrations but not with pain-related cerebral processing in fibromyalgia subjects and healthy controls.
    Ellerbrock I; Sandström A; Tour J; Fanton S; Kadetoff D; Schalling M; Jensen KB; Sitnikov R; Kosek E
    Mol Brain; 2021 May; 14(1):81. PubMed ID: 33980291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism in the µ-opioid receptor gene (OPRM1) modulates neural processing of physical pain, social rejection and error processing.
    Bonenberger M; Plener PL; Groschwitz RC; Grön G; Abler B
    Exp Brain Res; 2015 Sep; 233(9):2517-26. PubMed ID: 26019010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network.
    Jensen KB; Loitoile R; Kosek E; Petzke F; Carville S; Fransson P; Marcus H; Williams SC; Choy E; Mainguy Y; Vitton O; Gracely RH; Gollub R; Ingvar M; Kong J
    Mol Pain; 2012 Apr; 8():32. PubMed ID: 22537768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The OPRM1 A118G polymorphism modulates the descending pain modulatory system for individual pain experience in young women with primary dysmenorrhea.
    Wei SY; Chen LF; Lin MW; Li WC; Low I; Yang CJ; Chao HT; Hsieh JC
    Sci Rep; 2017 Jan; 7():39906. PubMed ID: 28057931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of OPRM1 rs1799971, HTR1B rs6296 and COMT rs4680 polymorphisms with clinical phenotype among women with fibromyalgia.
    Fernández-de-Las-Peñas C; Ambite-Quesada S; Fernández-Méndez LM; Jiménez-Antona C; Gómez-Calero C; Pocinho R; Valera-Calero JA; Cigarán-Méndez M; Arendt-Nielsen L
    Sci Rep; 2024 May; 14(1):11273. PubMed ID: 38760456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
    Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
    Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.
    Fillingim RB; Kaplan L; Staud R; Ness TJ; Glover TL; Campbell CM; Mogil JS; Wallace MR
    J Pain; 2005 Mar; 6(3):159-67. PubMed ID: 15772909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic influences on the dynamics of pain and affect in fibromyalgia.
    Finan PH; Zautra AJ; Davis MC; Lemery-Chalfant K; Covault J; Tennen H
    Health Psychol; 2010 Mar; 29(2):134-42. PubMed ID: 20230086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis.
    Yu Z; Wen L; Shen X; Zhang H
    Clin J Pain; 2019 Jan; 35(1):77-86. PubMed ID: 30028366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Painful After-Sensations in Fibromyalgia are Linked to Catastrophizing and Differences in Brain Response in the Medial Temporal Lobe.
    Schreiber KL; Loggia ML; Kim J; Cahalan CM; Napadow V; Edwards RR
    J Pain; 2017 Jul; 18(7):855-867. PubMed ID: 28300650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues.
    Ray LA; Courtney KE; Hutchison KE; Mackillop J; Galvan A; Ghahremani DG
    Alcohol Clin Exp Res; 2014 Jan; 38(1):78-89. PubMed ID: 23876228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct aberrations in cerebral pain processing differentiating patients with fibromyalgia from patients with rheumatoid arthritis.
    Sandström A; Ellerbrock I; Löfgren M; Altawil R; Bileviciute-Ljungar I; Lampa J; Kosek E
    Pain; 2022 Mar; 163(3):538-547. PubMed ID: 34224497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relevance of the OPRM1 118A>G Genetic Variant for Opioid Requirement in Pain Treatment: A Meta-Analysis.
    Zhang X; Liang Y; Zhang N; Yan Y; Liu S; Fengxi H; Zhao D; Chu H
    Pain Physician; 2019 Jul; 22(4):331-340. PubMed ID: 31337162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.